Company profile
Amplia Therapeutics Ltd. company profile
Amplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2016-01-01
Headquarters
- Headquarters
- North Melbourne, Victoria, Australia
- Postal code
- 3051
- Country code
- AU
- Continent
- Oceania